ACVR2B and familial dilated cardiomyopathy: In contrast to DCM patients, we could not detect any difference in either Mstn (Figure 1A) or ActRIIB transcript levels (Figure 1B) or in Mstn signaling index (Figure 1C) in any heart region of ICM patients compared to those of CONT.